It’s pretty rare to see well-funded medical device companies fly so smoothly under the radar, but Pennsylvania surgical reconstruction startup TELA Bio has done just that – it’s raised $45.3 million in equity, according to a regulatory filing. But that’s practically all we know.
The company held two funding rounds prior – $6 million in 2013 and $16.1 million in 2012. It’s led by Antony Koblish, who led orthobiologics maker Orthovita until it was sold three years ago to Stryker for $316 million.
Orthovita – and now Stryker – creates regenerative protein-based products for synthetic bone grafts. So what does TELA Bio do? Probably something quite similar.
Help employers find you! Check out all the jobs and post your resume.
